| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PHC Co.Ltd (KQ: 057880)
057880 Technical Analysis
5
| As on 22nd Mar 2022 057880 SHARE Price closed @ 1740.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2507.23 & Strong Sell for SHORT-TERM with Stoploss of 4011.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
057880SHARE Price
| Open | 1690.00 | Change | Price | % |
| High | 1770.00 | 1 Day | 45.00 | 2.65 |
| Low | 1680.00 | 1 Week | -75.00 | -4.13 |
| Close | 1740.00 | 1 Month | -20.00 | -1.14 |
| Volume | 8010318 | 1 Year | -5130.00 | -74.67 |
| 52 Week High 7160.00 | 52 Week Low 929.00 | ||||
KQ Korea Most Active Stocks
| 001470 | 4730.00 | -4.25% |
| 001470 | 4730.00 | -4.25% |
| 022100 | 20250.00 | 27.36% |
| 032820 | 1581.00 | 11.65% |
| 027580 | 2190.00 | 7.09% |
| 006910 | 4025.00 | 8.93% |
| 000040 | 670.00 | 12.42% |
| 000040 | 670.00 | 12.42% |
| 073640 | 7470.00 | 23.88% |
| 214870 | 1383.00 | -27.44% |
KQ Korea Top Gainers Stocks
KQ Korea Top Losers Stocks
| 057880 Daily Charts |
057880 Intraday Charts |
Whats New @ Bazaartrend |
057880 Free Analysis |
|
|
057880 Important Levels Intraday
| RESISTANCE | 1913.43 |
| RESISTANCE | 1857.81 |
| RESISTANCE | 1823.43 |
| RESISTANCE | 1789.05 |
| SUPPORT | 1690.95 |
| SUPPORT | 1656.57 |
| SUPPORT | 1622.19 |
| SUPPORT | 1566.57 |
057880 Forecast April 2024
| 4th UP Forecast | 7463.19 |
| 3rd UP Forecast | 5627.73 |
| 2nd UP Forecast | 4493.19 |
| 1st UP Forecast | 3358.65 |
| 1st DOWN Forecast | 121.35 |
| 2nd DOWN Forecast | -1013.19 |
| 3rd DOWN Forecast | -2147.73 |
| 4th DOWN Forecast | -3983.19 |
057880 Weekly Forecast
| 4th UP Forecast | 7983.48 |
| 3rd UP Forecast | 5981.16 |
| 2nd UP Forecast | 4743.48 |
| 1st UP Forecast | 3505.80 |
| 1st DOWN Forecast | -25.80 |
| 2nd DOWN Forecast | -1263.48 |
| 3rd DOWN Forecast | -2501.16 |
| 4th DOWN Forecast | -4503.48 |
057880 Forecast2024
| 4th UP Forecast | 16198.3 |
| 3rd UP Forecast | 11561.4 |
| 2nd UP Forecast | 8695.28 |
| 1st UP Forecast | 5829.14 |
| 1st DOWN Forecast | -2349.14 |
| 2nd DOWN Forecast | -5215.28 |
| 3rd DOWN Forecast | -8081.43 |
| 4th DOWN Forecast | -12718.3 |
PHC Co.Ltd ( KQ Korea Symbol : 057880 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
057880 Business Profile
PHC Co.,Ltd. engages in the medical drug, bio, medical, and distribution businesses in South Korea and internationally. The company develops Nex Bio drugs for the treatment of hemophilia A, anemia, hormone, and macular degeneration diseases. It also offers various bio products, including house dust mite removers under the FromG brand name; and orthopedic biotransplant fusion medical devices. In addition, it distributes various products through domestic home shopping, data broadcasting, and B2B delivery channels. PHC Co.,Ltd. was founded in 1998 and is based in Seongnam, South Korea. Address: 23, Jungjail-ro, Seongnam-si, South Korea, 463-869
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service